Japa (Hibiscus)

Hibiscus rosa-sinensis
Japa (Hibiscus rosa-sinensis), or Gudhal, is a widely recognized flowering plant in Ayurveda. Its flowers, leaves, and roots are traditionally used for their supposed balancing effects on Pitta and Kapha doshas. This vibrant plant is prevalent across tropical and subtropical regions, valued for its claimed benefits in hair health and cooling properties.
PLANT FAMILY
Malvaceae (Mallow)
PARTS USED
Flowers, Leaves, Root
AYURVEDIC ACTION
Pitta ↓, Kapha ↓
ACTIVE COMPOUNDS
Flavonoids (0.5-1%)

What is Japa (Hibiscus)?

Japa, commonly known as Hibiscus (Hibiscus rosa-sinensis), is a widespread flowering plant in the Malvaceae (Mallow) family, native to tropical and subtropical regions. This evergreen shrub is distinguished by its large, showy, trumpet-shaped flowers that come in a diverse array of colors, including red, pink, white, and yellow.

Beyond its ornamental appeal, various parts of the hibiscus plant, including its flowers, leaves, and roots, have been traditionally utilized in various cultures for their medicinal and culinary properties, making it a plant of both aesthetic and practical significance.

Other Names of Hibiscus

  • Rose Mallow
  • China Rose
  • Shoe Flower
  • Tropical Hibiscus
  • Gudhal

Benefits of Japa (Hibiscus)

Heading

<h3> Absolute Contraindications of Japa (Hibiscus) </h3> <h4> Pregnancy / Trying to conceive [Avoid during pregnancy]</h4> <ul> <li> 🤰 <li> Recommendation: Do not use hibiscus extracts, teas, or concentrated supplements if you are pregnant or actively trying to conceive. <li> Reasoning: Animal studies show hibiscus extracts can alter uterine function and produce anti-implantation effects at experimental doses; until human safety is established, avoidance in pregnancy is advised. <li> Scientific_Study_Title: Post-Coital Antifertility Activity of Hibiscus rosa-sinensis Linn. roots. <li> Scientific_Study_Authors: Neeru Vasudeva, S.K. Sharma. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/18317554/ <li> Scientific_Study_Excerpt: <p>Summary: In rodent experiments the ethanolic root extract of Hibiscus rosa-sinensis produced strong anti-implantation (100% inhibition at 400 mg/kg) and uterotropic (estrogenic/uterus-affecting) effects. Histological findings supported interference with normal implantation and uterine physiology. The authors conclude that the root extract displays contraceptive/anti-implantation effects in this animal model, supporting traditional use but raising safety concerns for pregnancy.</p> </li> </ul> <h4>Concurrent use with chloroquine / primaquine (malaria treatment) [If you are being treated for malaria or taking chloroquine-class medicines]</h4> <ul> <li> ⚠️ <li> Recommendation: Avoid consuming hibiscus tea or preparations at the time you take chloroquine/primaquine; do not drink hibiscus close to your antimalarial dosing. <li> Reasoning: A controlled human study showed that common hibiscus beverages dramatically reduced chloroquine blood levels (AUC and Cmax), which could reduce efficacy of the antimalarial and risk treatment failure. <li> Scientific_Study_Title: Significant reduction in chloroquine bioavailability following coadministration with the Sudanese beverages Aradaib, Karkadi and Lemon. <li> Scientific_Study_Authors: H. A. M. Abdalla, et al. (authors listed on PubMed entry). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/8089046/ <li> Scientific_Study_Excerpt: <p>Summary: In healthy male volunteers, taking 600 mg chloroquine with the common Sudanese hibiscus beverage ("Karkadi") led to a marked reduction in chloroquine area under the curve (AUC) and peak plasma concentration (Cmax) compared with water - reductions that were statistically significant. The authors warn that reduced chloroquine bioavailability after concurrent consumption of hibiscus beverages may lower antimalarial efficacy.</p> </li> </ul> <h4>Concurrent use with vitamin K antagonist anticoagulants without medical supervision [People on warfarin / acenocoumarol]</h4> <ul> <li> 🩸 <li> Recommendation: If you take warfarin or similar blood-thinning medications, avoid starting hibiscus products without close medical monitoring (INR checks) and prescriber guidance. <li> Reasoning: Post-marketing surveillance and case reports have documented both reductions and increases in INR after starting herbal preparations containing hibiscus, suggesting unpredictable effects on anticoagulant control in some patients. <li> Scientific_Study_Title: Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health Products. <li> Scientific_Study_Authors: G. Rossi, M. Menniti-Ippolito, et al. <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025393/ <li> Scientific_Study_Excerpt: <p>Summary: Analysis of spontaneous reports identified several cases where patients on warfarin or acenocoumarol experienced clinically relevant changes in INR after starting herbal products that included Hibiscus sabdariffa among other ingredients. Some reports documented INR reduction (loss of anticoagulant effect) and others INR increase; dechallenge often improved the situation, supporting a possible relationship, and study authors advise caution and monitoring.</p> </li> </ul> <h3> Relative Contraindications of Japa (Hibiscus) </h3> <h4>Use with prescription antihypertensive medications [If you already take BP drugs]</h4> <ul> <li> 💊 <li> Recommendation: Consult your prescribing clinician before adding hibiscus; dosing should be supervised and BP monitored if used together. <li> Reasoning: Hibiscus has proven BP-lowering effects in clinical trials; when taken with ACE inhibitors, ARBs, beta-blockers or other antihypertensives it may add to blood-pressure lowering and increase dizziness or symptomatic hypotension. <li> Scientific_Study_Title: Efficacy of Hibiscus sabdariffa on Reducing Blood Pressure in Patients With Mild-to-Moderate Hypertension: A Systematic Review and Meta-Analysis. <li> Scientific_Study_Authors: Abdelaziz M. Negida, et al. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34694241/ <li> Scientific_Study_Excerpt: <p>Summary: Meta-analysis of randomized trials found that hibiscus significantly reduced systolic and diastolic blood pressure versus placebo. The authors note reductions were meaningful in mild-to-moderate hypertension, supporting caution when combining hibiscus with prescription antihypertensives because additive BP lowering is likely.</p> </li> </ul> <h4>Use with diuretics / electrolyte-altering drugs [People on loop or thiazide diuretics]</h4> <ul> <li> 💧 <li> Recommendation: Use cautiously and monitor electrolytes and blood pressure; discuss with your provider. <li> Reasoning: Clinical work showed hibiscus can change urinary sodium handling and serum electrolytes (natriuresis); combining with diuretics may amplify electrolyte shifts or volume loss. <li> Scientific_Study_Title: Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. <li> Scientific_Study_Authors: Herrera-Arellano A, et al. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/17315307/ <li> Scientific_Study_Excerpt: <p>Summary: In a randomized controlled trial vs lisinopril, hibiscus extract decreased BP and produced detectable changes in serum chloride and a trend to lower sodium, consistent with natriuretic/diuretic activity. The study authors report safety but recommend monitoring of electrolytes in susceptible patients.</p> </li> </ul> <h4>Use with antidiabetic medications [If you are on insulin or glucose-lowering drugs]</h4> <ul> <li> 🍬 <li> Recommendation: Monitor blood glucose more closely if you add hibiscus; adjust medications only under medical supervision. <li> Reasoning: Human and animal studies show hibiscus can lower postprandial and fasting glucose modestly; combining with antidiabetic drugs could increase hypoglycemia risk. <li> Scientific_Study_Title: Antidiabetic Effect of Rosella-Stevia Tea on Prediabetic Women in Yogyakarta, Indonesia. <li> Scientific_Study_Authors: R. H. Sumarno, et al. (study authors as listed on PubMed entry) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/29425471/ <li> Scientific_Study_Excerpt: <p>Summary: In a small controlled study of prediabetic women, flavored roselle (Hibiscus sabdariffa) infusion significantly lowered fasting blood glucose after 14 days of twice-daily consumption. Authors note potential benefits but recommend caution when combined with glucose-lowering drugs because additive effects are plausible.</p> </li> </ul> <h4>Use with multiple drugs metabolised by CYP enzymes [Patients on many prescription medications]</h4> <ul> <li> 🔬 <li> Recommendation: If you take multiple medications metabolized by liver CYP enzymes (e.g., CYP3A4 substrates), consult a pharmacist or clinician before using concentrated hibiscus extracts; monitoring or spacing doses may be needed. <li> Reasoning: In vitro studies show hibiscus extracts can inhibit multiple CYP isoforms; while clinical significance is not fully proven, inhibition suggests the potential to alter drug levels of co-medications. <li> Scientific_Study_Title: In vitro inhibitory activities of the extract of Hibiscus sabdariffa L. on selected cytochrome P450 isoforms. <li> Scientific_Study_Authors: O. Abubakar, et al. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/24146485/ <li> Scientific_Study_Excerpt: <p>Summary: The ethanolic extract of H. sabdariffa inhibited multiple human CYP isoforms in vitro (including CYP3A4, CYP2D6, CYP2C19 and others) at micromolar concentrations. Authors caution that although in vitro inhibition doesn't guarantee clinical interactions, coadministration with drugs metabolized by these enzymes warrants careful consideration and further clinical study.</p> </li> </ul>

Heading

<h4> Symptomatic low blood pressure / dizziness </h4> <ul> <li> ⚠️ <li> Side effect summary: Some people experience lightheadedness or low blood pressure when consuming hibiscus, especially if they already take BP-lowering drugs. <li> Recommendation: Stop or reduce intake if you feel dizzy; check BP regularly and speak with your clinician if symptomatic. <li> Reasoning: Clinical trials and meta-analyses document modest but real reductions in systolic and diastolic blood pressure; in combination with other BP-lowering factors this can cause symptomatic hypotension. <li> Severity Level: Moderate <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Efficacy of Hibiscus sabdariffa on Reducing Blood Pressure in Patients With Mild-to-Moderate Hypertension: A Systematic Review and Meta-Analysis. <li> Scientific_Study_Authors: Abdelaziz M. Negida, et al. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34694241/ <li> Scientific_Study_Excerpt: <p>Summary: Across randomized trials, hibiscus reduced SBP and DBP compared with placebo. While reductions were modest on average, the pooled effect supports a blood-pressure lowering effect that can be clinically relevant when combined with antihypertensive therapy - recommending monitoring and dose caution.</p> </li> </ul> <h4> Changes in anticoagulation control (INR variability) </h4> <ul> <li> 🩺 <li> Side effect summary: Some patients on warfarin or similar drugs experienced meaningful INR changes after starting herbal products containing hibiscus. <li> Recommendation: Do not start hibiscus without informing your anticoagulation provider; obtain INR monitoring if exposure occurs. <li> Reasoning: Spontaneous surveillance reports link herbal supplements including hibiscus to both increases and decreases in INR, suggesting unpredictable effects on anticoagulant control in susceptible individuals. <li> Severity Level: Severe <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health Products. <li> Scientific_Study_Authors: Rossi G., Menniti-Ippolito M., et al. <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025393/ <li> Scientific_Study_Excerpt: <p>Summary: Surveillance data (2002-2009) included several cases where patients on vitamin-K antagonists had INR reductions or increases after starting herbal preparations that listed hibiscus among ingredients. Outcomes improved after stopping the herbal product in many cases; authors recommend caution and monitoring.</p> </li> </ul> <h4> Gastrointestinal upset (nausea, mild stomach discomfort) </h4> <ul> <li> 🤢 <li> Side effect summary: Occasional mild GI symptoms such as nausea or stomach cramps are reported with hibiscus consumption, usually transient. <li> Recommendation: Reduce dose or avoid intake on an empty stomach; seek medical care if severe or persistent. <li> Reasoning: Anecdotal reports and consumer safety summaries note mild GI effects in a minority of users; robust clinical trials report low adverse-event rates but acknowledge minor GI complaints can occur. <li> Severity Level: Mild <li> Scientific_Study_Available: NA <li> Scientific_Study_Title: NA <li> Scientific_Study_Authors: NA <li> Scientific_Study_Link: NA <li> Scientific_Study_Excerpt: NA </li> </ul>

Heading

<h4>Chloroquine / Primaquine (antimalarials)</h4> <ul> <li> Interaction_Details: Drinking hibiscus beverages at the time of taking chloroquine significantly reduces chloroquine plasma concentrations (AUC and Cmax), risking reduced antimalarial efficacy. <li> Severity: Severe <li> Recommendation: Avoid concurrent use; do not drink hibiscus tea at or near the time of taking chloroquine/primaquine and discuss alternatives with your prescriber. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/8089046/ <li> Scientific_Study_Title: Significant reduction in chloroquine bioavailability following coadministration with the Sudanese beverages Aradaib, Karkadi and Lemon. <li> Scientfic_Study_Authors: Abdalla SH, et al. (authors as listed in PubMed record) <li> Scientific_Study_Excerpt: <p>Summary: In a human pharmacokinetic study, coadministration of chloroquine with the hibiscus beverage "Karkadi" produced statistically significant reductions in chloroquine AUC and peak concentration compared to water. Authors warn that this interaction could lower drug efficacy and recommend avoiding simultaneous consumption.</p> </li> </ul> <h4>Vitamin K antagonists (warfarin, acenocoumarol)</h4> <ul> <li> Interaction_Details: Case reports and spontaneous surveillance data have linked herbal preparations containing hibiscus to unpredictable changes in INR (both increases and decreases). <li> Severity: Moderate <li> Recommendation: Do not start hibiscus without clinician/pharmacist advice; if exposure occurs, increase frequency of INR monitoring and consider temporary discontinuation until stable. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025393/ <li> Scientific_Study_Title: Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health Products. <li> Scientfic_Study_Authors: Rossi G., Menniti-Ippolito M., et al. <li> Scientific_Study_Excerpt: <p>Summary: Surveillance analysis identified multiple reports where natural health products including hibiscus were associated with changes in anticoagulation control. Some patients experienced reduced INR (risking thrombosis) while others had increased INR (bleeding risk); outcomes often improved when the herbal product was stopped.</p> </li> </ul> <h4>Antihypertensive agents (ACE inhibitors, ARBs, beta-blockers, calcium channel blockers)</h4> <ul> <li> Interaction_Details: Hibiscus lowers blood pressure on its own; combining it with prescription antihypertensives may produce additive blood-pressure lowering and symptomatic hypotension. <li> Severity: Moderate <li> Recommendation: If you take BP meds, consult your prescriber before using hibiscus; monitor BP (home or clinic) and report dizziness or syncope. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34694241/ <li> Scientific_Study_Title: Efficacy of Hibiscus sabdariffa on Reducing Blood Pressure in Patients With Mild-to-Moderate Hypertension: A Systematic Review and Meta-Analysis. <li> Scientfic_Study_Authors: Abdelaziz M. Negida, et al. <li> Scientific_Study_Excerpt: <p>Summary: Pooled randomized trials show hibiscus lowers systolic and diastolic BP versus placebo. Clinicians should anticipate additive effects if hibiscus is taken alongside prescription antihypertensives and adjust monitoring or therapy as needed.</p> </li> </ul> <h4>Diuretics (thiazides, loop diuretics) and electrolyte-affecting drugs</h4> <ul> <li> Interaction_Details: Hibiscus has natriuretic effects and can alter serum electrolytes; coadministration may enhance electrolyte loss or cause unexpected electrolyte shifts. <li> Severity: Moderate <li> Recommendation: Monitor electrolytes and volume status if using hibiscus with diuretics; avoid in patients at high risk for dehydration without clinical oversight. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/17315307/ <li> Scientific_Study_Title: Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. <li> Scientfic_Study_Authors: Herrera-Arellano A., Alvarez L., et al. <li> Scientific_Study_Excerpt: <p>Summary: In a 4-week randomized study, hibiscus extract reduced blood pressure and produced measurable changes in serum chloride and a trend to lower sodium consistent with natriuretic-diuretic effects; authors note monitoring of electrolytes in susceptible patients.</p> </li> </ul> <h4>Drugs metabolized by cytochrome P450 enzymes (many common medications: statins, some antidepressants, etc.)</h4> <ul> <li> Interaction_Details: In vitro evidence shows hibiscus extracts inhibit multiple human CYP isoforms (including CYP3A4, CYP2D6, CYP2C19); this could raise or lower levels of co-medications depending on the pathway involved. <li> Severity: Mild-Moderate <li> Recommendation: For critical-dose drugs metabolized by CYP enzymes, consult a pharmacist/clinician before using concentrated hibiscus extracts; consider spacing or monitoring drug levels as advised. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/24146485/ <li> Scientific_Study_Title: In vitro inhibitory activities of the extract of Hibiscus sabdariffa L. on selected cytochrome P450 isoforms. <li> Scientfic_Study_Authors: Abass K., Turpeinen M., Pelkonen O., et al. <li> Scientific_Study_Excerpt: <p>Summary: Ethanolic extract of H. sabdariffa inhibited nine major drug-metabolizing CYP isoforms in human liver microsomal assays with IC50 values in the hundreds of micrograms per mL. Authors state clinical significance is uncertain but advise caution pending clinical interaction studies.</p> </li> </ul>